Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)



Status:Completed
Conditions:Constipation
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:10 - Any
Updated:8/18/2018
Start Date:October 2007
End Date:August 2018

Use our guide to learn which trials are right for you!

Patients undergoing routine rectal suction biopsy will undergo as part of the study an
additional Endoscopic mucosal resection. The biopsy results will also be correlated with
patient's clinical data including clinical history, Bristol stool scale, anorectal manometry
results, and SITZ marker studies. Cost and recovery time will be compared.

Background: Adult and pediatric patients presenting with chronic constipation and/or motility
disorders may be referred for rectal biopsy to rule out aganglionosis or Hirschsprung's
disease. The traditional diagnostic test, rectal suction biopsy, is a blind technique and is
insensitive in confirming the diagnosis. Frequently, patients require subsequent referral for
a surgical full thickness biopsy.

Hypothesis: Endoscopic mucosal resection (EMR) will improve the diagnostic yield for
aganglionosis and decrease the need for subsequent surgical full thickness biopsy.

Methods: This is a prospective, single center, controlled investigation of EMR for the
diagnosis of colonic aganglionosis / Hirschsprung's disease. Patients who are offered rectal
suction biopsy will be offered enrollment. Enrolled patients will have one additional
procedure (EMR) at the time of their rectal suction biopsy. Specimens will be analyzed
pathologically for size, submucosal tissue adequacy, the presence of ganglionic tissue, and
positivity by acetylcholinesterase staining. The adequacy of the tissue specimen, the
proportion of diagnostic specimens, and the proportion of patients that would have required
subsequent referral for full thickness biopsy, will be compared. Variable such as cost and
recovery time will be compared. Biopsy results will be compared with patient's pre-endoscopy
clinical data including their history of constipation, results of SITZ marker studies,
Bristol stool scale, and anorectal manometry.

Results: The primary outcome variable will be the proportion of patients with a diagnostic
specimen in each group. Secondary outcome variables will include the size of the specimen,
the presence of ganglionic tissue, the presence of submucosal tissue, and the positivity of
the acetylcholinesterase stain. The biopsy results will also be correlated with patient's
clinical data including clinical history, Bristol stool scale, anorectal manometry results,
and SITZ marker studies. Cost and recovery time will be compared.

Discussion: The proposed investigation may demonstrate that a simple endoscopic test, which
uses direct visualization, can improve the diagnostic yield of rectal biopsies for
Hirschsprung's disease, and spare patients an additional surgical full thickness rectal
biopsy.

Inclusion Criteria:

- 10 years of age or older

- offered Rectal Suction biopsy

Exclusion Criteria:

- any contraindication to general anesthesia or conscious sedation

- contraindication to endoscopy

- untreated or unmanageable coagulopathy

- thrombocytopenia (<50)

- inability to provide informed consent.
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
Principal Investigator: Braden Kuo, M.D.
Phone: 617-726-0196
?
mi
from
Boston, MA
Click here to add this to my saved trials